Using a patient-derived xenograft (PDX) model (Fig. 4a), we observed the functional consequences of p53 activation on chronic phase CML LSC engrafted in murine bone marrow (BM). The gene discussed is TP53; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.